NCT00578552View on ClinicalTrials.gov

Gabapentin for Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

May 31, 2009

Conditions
Cigarette SmokingTobacco Use
Interventions
DRUG

Placebo

Placebo pill - non active sugar pill designed to look alike to the gabapentin medication

DRUG

Gabapentin - 1800 mg/day

gabapentin - 1800 mg/day for 12 weeks.

DRUG

Gabapentin - 2700 mg/day

gabapentin - 2700 mg/day for 12 weeks.

Trial Locations (1)

55905

Mayo Clinic Nicotine Research Program, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER